202 related articles for article (PubMed ID: 18359419)
1. Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy.
Gursel G; Aydogdu M; Ozyilmaz E; Ozis TN
J Crit Care; 2008 Mar; 23(1):34-40. PubMed ID: 18359419
[TBL] [Abstract][Full Text] [Related]
2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
3. Infections in a surgical intensive care unit of a university hospital in Greece.
Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S
Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663
[TBL] [Abstract][Full Text] [Related]
4. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
5. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM
J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721
[TBL] [Abstract][Full Text] [Related]
6. Impact of intensive-care-unit(ICU)-acquired ventilator-associated pneumonia(VAP) on hospital mortality: a matched-paired case-control study.
Uno H; Takezawa J; Yatsuya H; Suka M; Yoshida K
Nagoya J Med Sci; 2007 Jan; 69(1-2):29-36. PubMed ID: 17378178
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
8. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors for the development of acute renal failure in patients with ventilator-associated pneumonia.
Gursel G; Demir N
Nephrology (Carlton); 2006 Jun; 11(3):159-64. PubMed ID: 16756626
[TBL] [Abstract][Full Text] [Related]
10. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
[TBL] [Abstract][Full Text] [Related]
11. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
12. Early- and late-onset ventilator-associated pneumonia acquired in the intensive care unit: comparison of risk factors.
Giard M; Lepape A; Allaouchiche B; Guerin C; Lehot JJ; Robert MO; Fournier G; Jacques D; Chassard D; Gueugniaud PY; Artru F; Petit P; Robert D; Mohammedi I; Girard R; Cêtre JC; Nicolle MC; Grando J; Fabry J; Vanhems P
J Crit Care; 2008 Mar; 23(1):27-33. PubMed ID: 18359418
[TBL] [Abstract][Full Text] [Related]
13. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia.
Gursel G; Demirtas S
Respiration; 2006; 73(4):503-8. PubMed ID: 16205047
[TBL] [Abstract][Full Text] [Related]
14. Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study.
Magret M; Amaya-Villar R; Garnacho J; Lisboa T; Díaz E; Dewaele J; Deja M; Manno E; Rello J;
J Trauma; 2010 Oct; 69(4):849-54. PubMed ID: 20938271
[TBL] [Abstract][Full Text] [Related]
15. Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients.
Karhu J; Ala-Kokko TI; Ylipalosaari P; Ohtonen P; Laurila JJ; Syrjälä H
Acta Anaesthesiol Scand; 2011 Nov; 55(10):1254-60. PubMed ID: 22092131
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
[TBL] [Abstract][Full Text] [Related]
17. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
18. Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial.
Shorr AF; Cook D; Jiang X; Muscedere J; Heyland D;
J Crit Care; 2008 Mar; 23(1):64-73. PubMed ID: 18359423
[TBL] [Abstract][Full Text] [Related]
19. An early predictor of the outcome of patients with ventilator-associated pneumonia.
Huang KT; Tseng CC; Fang WF; Lin MC
Chang Gung Med J; 2010; 33(3):274-82. PubMed ID: 20584505
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial pneumonia in the ICU: a prospective cohort study.
Hyllienmark P; Gårdlund B; Persson JO; Ekdahl K
Scand J Infect Dis; 2007; 39(8):676-82. PubMed ID: 17654343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
